Amanote Research

Amanote Research

    RegisterSign In

264. Translating RNAi Therapy for Spinocerebellar Ataxia 1 (SCA1) to the Clinic

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35277-7
Full Text
Open PDF
Abstract

Available in full text

Categories
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
Date

May 1, 2014

Authors

Unknown

Publisher

Elsevier BV


Related search

Gene Therapies for Spinocerebellar Ataxia Type 1

English

Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2019English

Spinocerebellar Ataxia With Axonal Neuropathy Type 1

2020English

Rod-Cone Dystrophy in Spinocerebellar Ataxia Type 1

Archives of Ophthalmology
2011English

Spinocerebellar Ataxia Type 13

2020English

Spinocerebellar Ataxia Type 3

2020English

Spinocerebellar Ataxia Type 8

2020English

Spinocerebellar Ataxia Type 12

2020English

Spinocerebellar Ataxia Type 37

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy